[Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D013565:Sympatholytics / Q000494:pharmacology* / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects
D000605:Amino Alcohols; D010919:Placebos; D011437:Propylamines; D013565:Sympatholytics; D011433:Propranolol
Hämodynamische Veränderungen nach Blockade der beta-Rezeptoren bei Gesunden und bei Patienten mit coronarer Herzkrankheit. Vergleich zwischen Trasicor und Inderal.